{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:06:35Z","timestamp":1793196395681,"version":"4.5.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","award":["NCT02758951"],"award-info":[{"award-number":["NCT02758951"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2020.02.011","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T14:08:30Z","timestamp":1584022110000},"page":"36-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up"],"prefix":"10.1016","volume":"47","author":[{"given":"S.","family":"Kusamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Lurvink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Govaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.J.T.","family":"De Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Van der Speeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Barrios-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almog","family":"Ben-Yaacov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella","family":"Bertulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cashin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Goere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuno","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Loggie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviram","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompiliu","family":"Piso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Reymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Spiliotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Verwaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcom S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yonemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.02.011_bib1","article-title":"The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on pseudomyxoma peritonei and peritoneal mesothelioma","author":"Lurvink","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib2","first-page":"935","article-title":"Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005","volume":"20","author":"Moolgavkar","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ejso.2020.02.011_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0019-5278.146897","article-title":"Global mesothelioma epidemic: trend and features","volume":"18","author":"Bianchi","year":"2014","journal-title":"Indian J Occup Environ Med"},{"key":"10.1016\/j.ejso.2020.02.011_bib4","first-page":"32","article-title":"Peritoneal mesothelioma: a review","volume":"9","author":"Bridda","year":"2007","journal-title":"MedGenMed"},{"key":"10.1016\/j.ejso.2020.02.011_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","article-title":"Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008","volume":"19","author":"Henley","year":"2013","journal-title":"Int J Occup Environ Health"},{"issue":"6","key":"10.1016\/j.ejso.2020.02.011_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/CEJ.0b013e3282f0c0a2","article-title":"US mesothelioma patterns 1973-2002: indicators of change and insights into background rates","volume":"17","author":"Teta","year":"2008","journal-title":"Eur J Canc Prev"},{"key":"10.1016\/j.ejso.2020.02.011_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdl345","article-title":"Epidemiology of peritoneal mesothelioma: a review","volume":"18","author":"Boffetta","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib8","doi-asserted-by":"crossref","DOI":"10.21037\/amj.2017.08.24","article-title":"International Early Lung Cancer Action Program: update on lung cancer screening and the management of CT screen-detected findings","volume":"2","author":"Chung","year":"2017","journal-title":"AME Med J"},{"key":"10.1016\/j.ejso.2020.02.011_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMoa1208962","article-title":"Results of the two incidence screenings in the National lung screening trial","volume":"369","author":"Aberle","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.02.011_bib10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/thoraxjnl-2016-209825","article-title":"Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial","volume":"72","author":"Paci","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.ejso.2020.02.011_bib11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: a multicenter study on 81 cases","volume":"21","author":"Manzini","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","article-title":"Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers","volume":"66","author":"Henderson","year":"2013","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib13","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the international mesothelioma interest group","author":"Husain","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejso.2020.02.011_bib14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Kusamura","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World health Organization classification of tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/jgh.13260","article-title":"CT differentiation of diffuse malignant peritoneal mesothelioma and peritoneal carcinomatosis","volume":"31","author":"Liang","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.ejso.2020.02.011_bib17","first-page":"1067","article-title":"Computed tomographic features of malignant peritoneal mesothelioma","volume":"36","author":"Kato","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2020.02.011_bib18","article-title":"Comparison of MRI and CT for predicting the peritoneal cancer index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures","author":"Low","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejso.2005.09.016","article-title":"Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"32","author":"de Bree","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/cncr.20836","article-title":"Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"103","author":"Yan","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.011_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11547-016-0682-x","article-title":"Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis","volume":"122","author":"Laghi","year":"2017","journal-title":"Radiol Med"},{"key":"10.1016\/j.ejso.2020.02.011_bib23","article-title":"Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation","author":"Low","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MNM.0000000000000649","article-title":"The role of 18F-FDG-PET\/ceCT in peritoneal mesothelioma","volume":"38","author":"Dubreuil","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ejso.2020.02.011_bib25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.ejso.2009.04.007","article-title":"Circulating CA125 and diffuse malignant peritoneal mesothelioma","volume":"35","author":"Baratti","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1245\/s10434-012-2651-5","article-title":"A\u00a0novel nomogram for peritoneal mesothelioma predicts survival","volume":"20","author":"Schaub","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib27","doi-asserted-by":"crossref","first-page":"9190","DOI":"10.1074\/jbc.M312372200","article-title":"Binding of ovarian cancer antigen CA125\/MUC16 to mesothelin mediates cell adhesion","volume":"279","author":"Rump","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ejso.2020.02.011_bib28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejso.2018.02.010","article-title":"Mesothelin and osteopontin as circulating markers of diffuse malignant peritoneal mesothelioma: a preliminary study","volume":"44","author":"Bruno","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib29","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1158\/1078-0432.CCR-14-0804","article-title":"Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma","volume":"20","author":"Hassan","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.ejso.2020.02.011_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/bjs.8908","article-title":"Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis","volume":"100","author":"Iversen","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2020.02.011_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00464-003-9139-0","article-title":"Minilaparoscopy in the diagnosis of peritoneal tumor spread: prospective controlled comparison with computed tomography","volume":"18","author":"Denzer","year":"2004","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2020.02.011_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s13193-015-0486-9","article-title":"Diagnostic laparoscopy in the pre-operative assessment of patients undergoing cytoreductive surgery and HIPEC for peritoneal surface malignancies","volume":"7","author":"Seshadri","year":"2016","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/02656736.2017.1338363","article-title":"Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms","volume":"34","author":"Tan","year":"2018","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2020.02.011_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/bjs.10723","article-title":"Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE)","volume":"105","author":"Passot","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2020.02.011_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/jso.21069","article-title":"Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: expert consensus statement","volume":"98","author":"Yan","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1245\/s10434-014-4136-1","article-title":"Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis","volume":"22","author":"Nunez","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2020.02.011_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/PPO.0b013e3181a58e93","article-title":"Laparoscopy in the management of peritoneal carcinomatosis","volume":"15","author":"Garofalo","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.ejso.2020.02.011_bib38","first-page":"187","article-title":"Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma","volume":"23","author":"Laterza","year":"2009","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.ejso.2020.02.011_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1472-6963-10-132","article-title":"What are the current barriers to effective cancer care coordination? A qualitative study","volume":"10","author":"Walsh","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ejso.2020.02.011_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejca.2013.11.012","article-title":"Policy statement on multidisciplinary cancer care","volume":"50","author":"Borras","year":"2014","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib41","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis","author":"Helm","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-5002(02)00180-0","article-title":"Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis","volume":"38","author":"Berghmans","year":"2002","journal-title":"Lung Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jso.10255","article-title":"Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion","volume":"83","author":"Deraco","year":"2003","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1081\/CNV-120023766","article-title":"Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma","volume":"21","author":"Le","year":"2003","journal-title":"Canc Invest"},{"key":"10.1016\/j.ejso.2020.02.011_bib45","first-page":"40","article-title":"Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program","volume":"7","author":"J\u00e4nne","year":"2005","journal-title":"Clin Lung Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","article-title":"Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent","volume":"64","author":"Carteni","year":"2009","journal-title":"Lung Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib47","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","article-title":"Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial","volume":"26","author":"Simon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/14737140.2017.1340157","article-title":"First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma","volume":"17","author":"Fujimoto","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejso.2020.02.011_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/030089161109700105","article-title":"Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience","volume":"97","author":"Lainakis","year":"2011","journal-title":"Tumori J"},{"key":"10.1016\/j.ejso.2020.02.011_bib50","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib51","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib52","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.ejso.2017.05.009","article-title":"Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: a RENAPE study","volume":"43","author":"Valmary-Degano","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib53","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ejso.2017.01.009","article-title":"Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival","volume":"43","author":"Sugarbaker","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib54","doi-asserted-by":"crossref","first-page":"66S","DOI":"10.1378\/chest.113.1_Supplement.66S","article-title":"A\u00a0review of chemotherapy trials for malignant mesothelioma","volume":"113","author":"Ryan","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ejso.2020.02.011_bib55","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","article-title":"The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"20","author":"Deraco","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","article-title":"Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: multi-Institutional Retrospective Study","volume":"65","author":"Kepenekian","year":"2016","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12032-018-1125-4","article-title":"The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking","volume":"35","author":"Naffouje","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib58","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1055-3207(03)00045-0","article-title":"A\u00a0review of peritoneal mesothelioma at the Washington cancer Institute","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg Oncol Clin N. Am"},{"key":"10.1016\/j.ejso.2020.02.011_bib59","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1200\/JCO.2003.04.150","article-title":"Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy","volume":"21","author":"Feldman","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib60","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0399-8320(07)73964-7","article-title":"Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy","volume":"31","author":"Elias","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.ejso.2020.02.011_bib61","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma","volume":"35","author":"Yano","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib62","doi-asserted-by":"crossref","first-page":"890450","DOI":"10.1155\/2012\/890450","article-title":"Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.ejso.2020.02.011_bib63","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1245\/s10434-017-6033-x","article-title":"Conversion to complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma after bidirectional chemotherapy","volume":"24","author":"Le Roy","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib64","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4149\/neo_2014_053","article-title":"Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma","volume":"61","author":"Kaya","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.ejso.2020.02.011_bib65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2020.02.011_bib66","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","article-title":"Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"49","author":"Baratti","year":"2013","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib67","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jso.21060","article-title":"The eligibility for local-regional treatment of peritoneal surface malignancy","volume":"98","author":"Verwaal","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib68","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","article-title":"Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib69","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1245\/s10434-018-6499-1","article-title":"Malignant peritoneal mesothelioma: National practice patterns, outcomes, and predictors of survival","volume":"25","author":"Verma","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib70","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1245\/s10434-015-4498-z","article-title":"Immunohistochemical evaluation of minichromosome maintenance protein 7 (MCM7), topoisomerase II\u03b1, and Ki-67 in diffuse malignant peritoneal mesothelioma patients using tissue microarray","volume":"22","author":"Deraco","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib71","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/cncr.25640","article-title":"A\u00a0novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database\u2217","volume":"117","author":"Yan","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.011_bib72","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1245\/s10434-017-6293-5","article-title":"Is cytoreductive surgery with hyperthermic intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the peritoneal surface oncology group international registry","volume":"25","author":"Votanopoulos","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00276-008-0456-9","article-title":"Peritoneal surface area: measurements of 40 structures covered by peritoneum: correlation between total peritoneal surface area and the surface calculated by formulas","volume":"31","author":"Albanese","year":"2009","journal-title":"Surg Radiol Anat"},{"key":"10.1016\/j.ejso.2020.02.011_bib74","first-page":"25","article-title":"Pathological evaluation and implications of serosal involvement in gastrointestinal cancer","volume":"169","author":"Ludeman","year":"2007","journal-title":"Recent Results Canc Res"},{"key":"10.1016\/j.ejso.2020.02.011_bib75","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","article-title":"Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study","volume":"19","author":"Baratti","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib76","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2006.05.009","article-title":"Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma","volume":"32","author":"Yan","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2020.02.011_bib77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1245\/s10434-009-0756-2","article-title":"Lymph node metastases in diffuse malignant peritoneal mesothelioma","volume":"17","author":"Baratti","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/s10434-008-0219-1","article-title":"Diffuse malignant peritoneal mesothelioma: failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"16","author":"Baratti","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib79","article-title":"Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome","volume":"1\u20136","author":"Ihemelandu","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib80","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1097-0142(197908)44:2<692::AID-CNCR2820440242>3.0.CO;2-6","article-title":"Multicystic, peritoneal mesothelioma: a report with electron microscopy of a case mimicking intra-abdominal cystic hygroma (lymphangioma)","volume":"44","author":"Mennemeyer","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.011_bib81","first-page":"340","article-title":"Multicystic peritoneal mesothelioma: a short review","volume":"41","author":"Zhang","year":"2017","journal-title":"Curr Probl Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jso.10081","article-title":"Malignant transformation of \u201cbenign\u201d cystic mesothelioma of the peritoneum","volume":"79","author":"Gonz\u00e1lez-Moreno","year":"2002","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib83","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ejso.2010.08.130","article-title":"Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","volume":"36","author":"Baratti","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib84","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ejso.2018.03.004","article-title":"Multicystic mesothelioma: operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy","volume":"44","author":"Nizri","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib85","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1245\/s10434-007-9475-8","article-title":"Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC)","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib86","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12957-015-0624-4","article-title":"Effects of sex hormones on survival of peritoneal mesothelioma","volume":"13","author":"Huang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0046-8177(77)80067-1","article-title":"Peritoneal mesothelioma","volume":"8","author":"Kannerstein","year":"1977","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.ejso.2020.02.011_bib88","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2559.1997.5460776.x","article-title":"Pathology of malignant mesothelioma","volume":"30","author":"Attanoos","year":"1997","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.ejso.2020.02.011_bib89","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00000478-198810000-00001","article-title":"Multicystic mesothelioma. An analysis of pathologic findings and biologic behavior in 37 cases","volume":"12","author":"Weiss","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib90","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PGP.0b013e3181f99def","article-title":"Multicystic mesothelioma caused by endometriosis: 2 case reports and review of the literature","volume":"30","author":"Kurisu","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib91","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/1097-0142(19890915)64:6<1336::AID-CNCR2820640628>3.0.CO;2-X","article-title":"Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas)","volume":"64","author":"Ross","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.011_bib92","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/030089160308900107","article-title":"Peritoneal cystic mesothelioma: a case series","volume":"89","author":"Sethna","year":"2003","journal-title":"Tumori J"},{"key":"10.1016\/j.ejso.2020.02.011_bib93","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.3748\/wjg.v12.i35.5739","article-title":"Benign multicystic peritoneal mesothelioma: a case report and review of the literature","volume":"12","author":"Safioleas","year":"2006","journal-title":"WJG"},{"key":"10.1016\/j.ejso.2020.02.011_bib94","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/hupa.2003.31","article-title":"Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status","volume":"34","author":"Sawh","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib95","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/ejso.2000.1215","article-title":"Peritoneal benign cystic mesothelioma: a case report and review of the literature","volume":"28","author":"van Ruth","year":"2002","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib96","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jogc.2017.04.038","article-title":"Remote recurrence of benign multicystic peritoneal mesothelioma","volume":"39","author":"Lee","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ejso.2020.02.011_bib97","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/15513818509026902","article-title":"Primitive cystic hepatic neoplasm of infancy with mesothelial differentiation: report of a case","volume":"4","author":"DeStephano","year":"1985","journal-title":"Pediatr Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib98","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200212","article-title":"Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature","author":"Mino","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ejso.2020.02.011_bib99","first-page":"87","article-title":"Malignant transformation in non-recurrent peritoneal cystic mesothelioma Our experience and review of the literature","volume":"29","author":"Santangelo","year":"2016","journal-title":"Ann Ital Chir"},{"key":"10.1016\/j.ejso.2020.02.011_bib100","first-page":"1","article-title":"Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival","volume":"58","author":"Gilani","year":"2018","journal-title":"Int J Hyperther"},{"key":"10.1016\/j.ejso.2020.02.011_bib101","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/dc.21192","article-title":"Cytomorphologic characteristics of fine needle core biopsy of multicystic peritoneal mesothelioma: a case report and review of the literature","volume":"38","author":"Kemp","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib102","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clinimag.2016.10.008","article-title":"Imaging appearance of benign multicystic peritoneal mesothelioma: a case report and review of the literature","volume":"42","author":"Mehta","year":"2017","journal-title":"Clin Imag"},{"key":"10.1016\/j.ejso.2020.02.011_bib103","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/rg.282075175","article-title":"From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation","volume":"28","author":"Levy","year":"2008","journal-title":"Radiographics"},{"issue":"39","key":"10.1016\/j.ejso.2020.02.011_bib104","article-title":"Diagnosis and treatment of benign multicystic peritoneal mesothelioma","volume":"19","author":"Wang","year":"2013","journal-title":"WJG"},{"key":"10.1016\/j.ejso.2020.02.011_bib105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s002619900387","article-title":"Giant benign cystic peritoneal mesothelioma: US, CT, and MRI findings","volume":"23","author":"Ozgen","year":"1998","journal-title":"Abdom Imag"},{"key":"10.1016\/j.ejso.2020.02.011_bib106","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/ijgc-00009577-200511000-00014","article-title":"Benign multicystic peritoneal mesothelioma: cases reports in the family with diverticulosis and literature review","volume":"15","author":"Tangjitgamol","year":"2005","journal-title":"Int J Gynecol Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib107","first-page":"157","article-title":"Benign cystic mesothelioma in a male patient: surgical treatment by the laparoscopic route","volume":"5","author":"Ricci","year":"1995","journal-title":"Surg Laparosc Endosc"},{"key":"10.1016\/j.ejso.2020.02.011_bib108","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00464-001-0052-0","article-title":"Peritoneal cystic mesothelioma","volume":"16","author":"Vara-Thorbeck","year":"2002","journal-title":"Surg Endosc"},{"key":"10.1016\/j.ejso.2020.02.011_bib109","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1159\/000346187","article-title":"Benign cystic mesothelioma of the peritoneum: a rare case and review of the literature","volume":"5","author":"Khuri","year":"2012","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5468\/ogs.2018.61.1.170","article-title":"Benign multicystic peritoneal mesothelioma treated with laparoendoscopic single site surgery: a case report and review of the literature","volume":"61","author":"Cha","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.ejso.2020.02.011_bib111","first-page":"99","article-title":"Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (HIPEC) by minimally invasive approach, an initial experience","volume":"7","author":"Arjona-S\u00e1nchez","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2020.02.011_bib112","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1097-0142(196311)16:11<1497::AID-CNCR2820161108>3.0.CO;2-W","article-title":"A\u00a0combined papillary mesothelioma and adenomatoid tumor of the omentum; report of A case","volume":"16","author":"Hanrahan","year":"1963","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.011_bib113","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/PAS.0000000000000200","article-title":"Well-differentiated papillary mesothelioma with invasive foci","volume":"38","author":"Churg","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib114","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/1097-0142(19900115)65:2<292::AID-CNCR2820650218>3.0.CO;2-W","article-title":"Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases","volume":"65","author":"Daya","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.02.011_bib115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib116","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/his.12089","article-title":"Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation","volume":"62","author":"Chen","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2020.02.011_bib117","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jjco\/hyt117","article-title":"Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum","volume":"43","author":"Lee","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib118","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1309\/AJCPOTO9LBB4UKWC","article-title":"Well-differentiated papillary mesothelioma of the peritoneum: a diagnostic dilemma on fine-needle aspiration cytology","volume":"142","author":"Nasit","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib119","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ygyno.2005.03.031","article-title":"Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature","volume":"98","author":"Hoekstra","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2020.02.011_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2018.05.001","article-title":"BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma","author":"Lee","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib121","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/00000478-199510000-00003","article-title":"Localized and diffuse mesotheliomas of the genital tract and peritoneum in women. A clinicopathologic study of nineteen true mesothelial neoplasms, other than adenomatoid tumors, multicystic mesotheliomas, and localized fibrous tumors","volume":"19","author":"Goldblum","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2020.02.011_bib122","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lungcan.2009.10.004","article-title":"Well-differentiated papillary mesothelioma with invasion to the chest wall","volume":"67","author":"Torii","year":"2010","journal-title":"Lung Canc"},{"key":"10.1016\/j.ejso.2020.02.011_bib123","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/crj.12057","article-title":"Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report","volume":"8","author":"Costanzo","year":"2014","journal-title":"Clin Respir J"},{"key":"10.1016\/j.ejso.2020.02.011_bib124","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF01606033","article-title":"Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature","volume":"417","author":"B\u00fcrrig","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib125","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00000478-200110000-00012","article-title":"Well-differentiated papillary mesothelioma","volume":"25","author":"Butnor","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2020.02.011_bib126","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/pin.12053","article-title":"Well-differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: a case report","volume":"63","author":"Washimi","year":"2013","journal-title":"Pathol Int"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832030113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074879832030113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:38:08Z","timestamp":1762310288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074879832030113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S074879832030113X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.02.011","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}